1,742
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: Oligmotetastases

A multi-national report on stereotactic body radiotherapy for oligometastases: Patient selection and follow-up*

, , , , , , & show all
Pages 633-637 | Received 20 Aug 2015, Accepted 01 Nov 2015, Published online: 04 Apr 2016

References

  • Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8–10.
  • Rabinovitch R, Kavanagh B. Double Helix of breast cancer therapy: intertwining the Halsted and Fisher hypotheses. J Clin Oncol 2009;27:2422–3.
  • Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378–82.
  • Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, et al. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 2009;9:621–35.
  • Videtic GM. The role of stereotactic radiotherapy in the treatment of oligometastases. Curr Oncol Rep 2014;16:391
  • Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–70.
  • Hoyer M, Muren LP. Stereotactic body radiation therapy - a discipline with Nordic origin and profile.. Acta Oncol 2012;51:564–7.
  • Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012;83:878–86.
  • Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, et al. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol 2014;4: e143–9.
  • Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2012;118:2962–70.
  • Carey Sampson M, Katz A, Constine LS. Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? Semin Radiat Oncol 2006;16:67–76.
  • Bartlett EK, Simmons KD, Wachtel H, Roses RE, Fraker DL, Kelz RR, et al. The rise in metastasectomy across cancer types over the past decade. Cancer 2015;121:747–57.
  • Barton MK. Metastasectomy on the rise across several cancer types. CA Cancer J Clin 2015;65:163–4.
  • Adam A, Kenny LM. Interventional oncology in multidisciplinary cancer treatment in the 21(st) century. Nat Rev Clin Oncol 2015;12:105–13.
  • Aitken K, Tree A, Thomas K, Nutting C, Hawkins M, Tait D, et al. Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: Can we change the therapeutic paradigm? Clin Oncol (R Coll Radiol) 2015;27:411–19.
  • NRG-BR001: A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases, 2014.
  • Palma DA, Haasbeek CJ, Rodrigues GB, Dahele M, Lock M, Yaremko B, et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial. BMC Cancer 2012;12:305.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.